HIV Therapy without HBV Co-management in Ethiopia Fosters Emergence of Unintended HBV Drug Resistance and Vaccine Evasive Variants

Código QR

HIV Therapy without HBV Co-management in Ethiopia Fosters Emergence of Unintended HBV Drug Resistance and Vaccine Evasive Variants

Guardado en:

Detalles Bibliográficos
Autores principales:	Y.B. Akal, M. Maier, U.G. Liebert
Formato:	article
Lenguaje:	EN
Publicado:	Ubiquity Press 2017
Materias:	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/43bc0efedebf4f83b75ef81ef0b84506
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mathematical Analysis of the Role of HIV/HBV Latency in Hepatocytes
por: Hasifa Nampala, et al.
Publicado: (2021)

Prevalence of HBV DNA in anti-HBe+ chronic HBV carriers in Babol, 2002
por: MR Hassanjani Roshan, et al.
Publicado: (2004)

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study
por: Haiyan Ma, et al.
Publicado: (2021)

Cytokines and Chemokines in HBV Infection
por: Shihong Zhong, et al.
Publicado: (2021)

Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Lei Ye, et al.
Publicado: (2017)

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.
por: Antonio Rivero-Juárez, et al.
Publicado: (2013)

Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya.
por: Mohamed A Daw, et al.
Publicado: (2014)

Epidemiology and Challenges of HBV/HIV Co-Infection Amongst HIV-Infected Patients in Endemic Areas: Review
por: Weldemhret L
Publicado: (2021)

Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression
por: Nghiem Xuan Hoan, et al.
Publicado: (2021)

Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Elsa Gomez-Escobar, et al.
Publicado: (2021)

Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF
por: Zhe-Bin Wu, et al.
Publicado: (2021)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Ling-Hao Zhao, et al.
Publicado: (2016)

Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression.
por: Nicola Coppola, et al.
Publicado: (2013)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
por: Ying Wang, et al.
Publicado: (2021)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Ling-Hao Zhao, et al.
Publicado: (2016)

Transgenic hepatitis B: a new model of HBV infection
por: Hubert D.-J. Daniel, et al.
Publicado: (2017)

MOLECULAR EPIDEMIOLOGY FEATURES OF HBV/HDV CO-INFECTION IN KYRGYZSTAN
por: A. V. Semenov, et al.
Publicado: (2016)

Transmission of HBV in patients with acute Hepatitis in Babol, 1996-98
por: MR Hassanjani Roshan
Publicado: (1999)

Novel evidence of HBV recombination in family cluster infections in western China.
por: Bin Zhou, et al.
Publicado: (2012)

Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
por: Takeshi Kurihara, et al.
Publicado: (2017)

CRYOGLOBULINEMIC VASCULITIS ASSOCIATED WITH HBV INFECTION: CLINICAL OBSERVATIONS AND LITERATURE REVIEW
por: N. V. Dunaeva, et al.
Publicado: (2014)

Analysis of a stochastic HBV infection model with delayed immune response
por: Fathalla A. Rihan, et al.
Publicado: (2021)

Prevalence of anti HDV in HBV carriers in Babol during 2000-02
por: MR Hassanjani Roshan, et al.
Publicado: (2004)

HBV Core Protein Is in Flux between Cytoplasmic, Nuclear, and Nucleolar Compartments
por: Smita Nair, et al.
Publicado: (2021)

Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
por: Hong Chen, et al.
Publicado: (2012)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: Anna L. McNaughton, et al.
Publicado: (2019)

Allosteric conformational changes of human HBV core protein transform its assembly
por: Chuang Liu, et al.
Publicado: (2017)

Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives
por: Omar HH
Publicado: (2019)

Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV
por: Shilin Yuan, et al.
Publicado: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Yandi Zhang, et al.
Publicado: (2021)

Оцінювання фіброзу печінки в дітей з хронічною HBV-інфекцією неінвазивними методами
por: V.S. Berezenko, et al.
Publicado: (2021)

Probing the spatiotemporal patterns of HBV multiplication reveals novel features of its subcellular processes.
por: Lei Yue, et al.
Publicado: (2021)

Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
por: Jimena Perez-Vargas, et al.
Publicado: (2019)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Katrin Manske, et al.
Publicado: (2021)

Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer
por: Xueke Wang, et al.
Publicado: (2021)

High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis
por: Xiangke Pu, et al.
Publicado: (2021)

Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
por: Jingjiao Song, et al.
Publicado: (2017)

Global sensitivity analysis of a single-cell HBV model for viral dynamics in the liver
por: Md Afsar Ali, et al.
Publicado: (2021)

A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV
por: Sitesh C. Bachar, et al.
Publicado: (2021)

Exosomal lncRNA HOTTIP Mediates Antiviral Effect of Tenofovir Alafenamide (TAF) on HBV Infection
por: Liu QM, et al.
Publicado: (2021)